Steven S. Williamson - 15 Mar 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
15 Mar 2024
Transactions value $
$0
Form type
4
Filing time
19 Mar 2024, 18:21:10 UTC
Previous filing
16 Feb 2024
Next filing
22 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Award $0 +205K $0.00 205K 15 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +425K $0.00 425K 15 Mar 2024 Common Stock 425K $8.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest in accordance with the following schedule: 25% vests on March 3, 2025, and the remainder of the award vests in equal quarterly installments over the subsequent three-year period.
F2 Twenty-five percent of the shares subject to the option vests on March 3, 2025, and the remainder vests in equal monthly installments over the subsequent three-year period.